While IDH1/IDH2 gliomas could be readily identified with 2-HG23, other types of gliomas might not be diagnosed with MS analysis of a single-compound biomarkers, which also applies for most of the cases for cancer diseases. This evidence concerns the gene IDH1 and central nervous system cancer.